Literature DB >> 12773479

Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells.

Hocine Slimani1, Nathalie Charnaux, Elisabeth Mbemba, Line Saffar, Roger Vassy, Claudio Vita, Liliane Gattegno.   

Abstract

It is believed that proteoglycans influence biological properties of chemokines. We show that the CC chemokine RANTES binds not only to high-affinity binding sites on CCR5-positive HeLa cells but also to low-affinity binding sites on HeLa cells expressing or lacking RANTES G protein-coupled receptors. Coimmunoprecipitation studies demonstrate that RANTES forms complexes with glycanated syndecan (SD)-1 and -4, in addition to CCR5 on the CCR5-positive HeLa cells. Moreover, confocal microscopy analysis shows the colocalization of RANTES with SD-1 and -4. Glycosaminoglycans removal from the cells by glycosaminidases treatment prevented RANTES binding to SD-1 and -4 and decreased RANTES binding to CCR5 on the CCR5-positive HeLa cells. Removal of glycosaminoglycans by glycosaminidases treatment of the complexes, RANTES/SD-1/SD-4/+/-CCR5, immobilized on beads, reversed SD-1 and -4 bindings. Therefore, RANTES bindings to SD-1 and -4 depend on glycosaminoglycans and facilitate RANTES interaction with CCR5. Extracting plasma membrane cholesterol abolished the coimmunoprecipitation of SD-1 with RANTES, suggesting that rafts are involved in RANTES association to SD-1. Confocal microscopy analysis as well as coimmunoprecipitation experiments show a RANTES-independent heteromeric complex on the CCR5-positive HeLa cells, SD-1, SD-4, and CCR5. This complex is likely a functional unit in which proteoglycans may modulate RANTES binding to CCR5.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773479     DOI: 10.1093/glycob/cwg083

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  14 in total

1.  Tumor necrosis factor-α- and interleukin-1β-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-κB axis: implications in inflammatory disc disease.

Authors:  Xin Wang; Hua Wang; Hao Yang; Jun Li; Qiqing Cai; Irving M Shapiro; Makarand V Risbud
Journal:  Am J Pathol       Date:  2014-07-22       Impact factor: 4.307

2.  Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells.

Authors:  Michael D Bobardt; Udayan Chatterji; Suganya Selvarajah; Bernadette Van der Schueren; Guido David; Bruce Kahn; Philippe A Gallay
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

3.  Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: a new opportunity for treating activated T cell-driven disease.

Authors:  Hideo Akiyoshi; Jin-Sung Chung; Mizuki Tomihari; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  J Immunol       Date:  2010-02-22       Impact factor: 5.422

4.  A whole genome association study of mother-to-child transmission of HIV in Malawi.

Authors:  Bonnie R Joubert; Ethan M Lange; Nora Franceschini; Victor Mwapasa; Kari E North; Steven R Meshnick
Journal:  Genome Med       Date:  2010-03-01       Impact factor: 11.117

5.  Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.

Authors:  Bonnie R Joubert; Nora Franceschini; Victor Mwapasa; Kari E North; Steven R Meshnick
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

6.  Heparan sulfates mediate the interaction between platelet endothelial cell adhesion molecule-1 (PECAM-1) and the Gαq/11 subunits of heterotrimeric G proteins.

Authors:  Nathaniel G dela Paz; Benot Melchior; Francisca Y Shayo; John A Frangos
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

7.  Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

Authors:  Michael D Bobardt; Patrick Salmon; Lianchun Wang; Jeffrey D Esko; Dana Gabuzda; Milan Fiala; Didier Trono; Bernadette Van der Schueren; Guido David; Philippe A Gallay
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway.

Authors:  Loïc Maillard; Naoaki Saito; Hanna Hlawaty; Véronique Friand; Nadine Suffee; Fanny Chmilewsky; Oualid Haddad; Christelle Laguillier; Erwan Guyot; Takehiko Ueyama; Olivier Oudar; Angela Sutton; Nathalie Charnaux
Journal:  Biol Open       Date:  2014-09-26       Impact factor: 2.422

9.  Syndecan-1 in the mouse parietal peritoneum microcirculation in inflammation.

Authors:  Paulina M Kowalewska; Amanda L Patrick; Alison E Fox-Robichaud
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

10.  Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes.

Authors:  Farida Djouad; Bruno Delorme; Marielle Maurice; Claire Bony; Florence Apparailly; Pascale Louis-Plence; François Canovas; Pierre Charbord; Danièle Noël; Christian Jorgensen
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.